Altamira Therapeutics Ltd. Lease And Sublease Payments Recognised As Expense
Altamira Therapeutics Ltd. (CYTOF) reported Lease And Sublease Payments Recognised As Expense of CHF 118.34 thousand for the 12-month period ending 2018-12-31, per its 20-F filed 2019-03-14.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:LeaseAndSubleasePaymentsRecognisedAsExpense · last filed 2019-03-14
| Period end | Lease And Sublease Payments Recognised As Expense 12 month |
|---|---|
| 2018-12-31 | 118.34K CHF 20-F · filed 2019-03-14 |
| 2017-12-31 | 192.96K CHF 20-F · filed 2019-03-14 |
| 2016-12-31 | 148.04K CHF 20-F · filed 2019-03-14 |
| 2015-12-31 | 107.45K CHF 20-F · filed 2018-03-22 |